Holly Watson

DNP Doctor of Nursing Practice,  Massachusetts General Hospital 

Location: India

Consulting Services

Admin and Customer Support Pharma-CRO-Device

Areas Of Interest

True Hermaphroditisms, Familial Hellebore, Stinking Thuja plicata alpha Filamin Capillary Zone Electrophoresis Dermatomyositis, Adult Type Ubiquitin Activating Enzyme E1 like Protein LIM Domain Proteins Ocular Infections Cytoplasmic Polyhedrosis Virus Thyroiditides, Subacute Costs, Hospital Transvenous Electric Ablation Sprycel Rehabilitation Surgeries, Orthopedic NSC-218321 Cassipourea Kinase, Proline-Directed Protein Preventive Dentistry Meksamine Receptors, Follicle Stimulating Hormone Surgeries, Minimally Invasive Acetyl CoA Synthetase T-Cell Receptor delta Genes Atrophy, Multisystemic Drinkings Computed Tomography, Helical Hydroxyestrones Tartrate Resistant Acid Phosphatase Interprofessional Relations Hydroxylase, Phenylalanine Stenosis, Tracheal

Professional Narrative

Dr. Holly Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Harvard Med 2018
Medical Writer, Harvard Med 1995

Education

Doctor of osteopathic medicine, Yale School of Medicine 2017
Bachelor of science in nursing, Harvard Medical School 2014

Referees


Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :